| Reboxetine |
990065 |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Италия |
31.33 |
6.27 |
37.6 |
4% |
1.25 |
32.58 |
6.52 |
39.1 |
16% |
5.01 |
37.59 |
7.52 |
45.11 |
Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 |
КЦ-707/09.03.2009; НСР-20812/13.02.2020 |
28.02.2020 |
02.03.2020 |
Активен |
658 |
| Reboxetine |
990065/22.06.2006 г. |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Italy |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 |
КЦ-707/09.03.2009 |
25.03.2009 |
02.01.2019 |
Неактивен |
658 |
| Reboxetine |
990065/22.06.2006 г. |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Протокол 140/22.10.2015 |
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
658 |
| Reboxetine |
0066/22.06.2007 г. |
Edronax, Tablet, 4, mg, Pack: 20 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
13.12 |
2.62 |
15.74 |
6% |
0.79 |
13.91 |
2.78 |
16.69 |
18% |
2.36 |
16.27 |
3.25 |
19.52 |
Цената се заличава с решение НСР-2231/20.12.2013 |
КЦРР-1071/26.07.2012 |
12.09.2012 |
12.09.2012 |
Заличен |
1357 |
| Reboxetine |
0066/22.06.2007 г. |
Edronax, Tablet, 4, mg, Pack: 20 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
14.08 |
2.82 |
16.9 |
6% |
0.84 |
14.92 |
2.98 |
17.9 |
18% |
2.53 |
17.45 |
3.49 |
20.94 |
|
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
1357 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
395.57 |
79.11 |
474.68 |
4% |
10 |
405.57 |
81.11 |
486.68 |
16% |
25 |
430.57 |
86.11 |
516.68 |
|
НСР-7784/28.12.2015; HCP-10174/31.08.2016; НСР-12821/26.05.2017 г. |
10.06.2017 |
02.07.2017 |
Активен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
414.26 |
82.85 |
497.11 |
4% |
10 |
424.26 |
84.85 |
509.11 |
16% |
25 |
449.26 |
89.85 |
539.11 |
|
НСР-7784/28.12.2015; HCP-10174/31.08.2016 |
02.10.2016 |
02.10.2016 |
Неактивен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
424.83 |
84.97 |
509.8 |
4% |
10 |
434.83 |
86.97 |
521.8 |
16% |
25 |
459.83 |
91.97 |
551.8 |
|
НСР-7784/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
428.13 |
85.63 |
513.76 |
4% |
10 |
438.13 |
87.63 |
525.76 |
16% |
25 |
463.13 |
92.63 |
555.76 |
|
НСР-4999/05.11.2014 |
19.11.2014 |
19.11.2014 |
Неактивен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
440.69 |
88.14 |
528.83 |
4% |
10 |
450.69 |
90.14 |
540.83 |
16% |
25 |
475.69 |
95.14 |
570.83 |
|
НСР-1076/02.09.2013 |
24.09.2013 |
24.09.2013 |
Неактивен |
3344 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
15.9 |
3.18 |
19.08 |
6% |
0.95 |
16.85 |
3.37 |
20.22 |
18% |
2.86 |
19.71 |
3.94 |
23.65 |
промяна на обстоятелства НСР-9775/14.07.2016; НСР-17431/06.12.2018 |
КЦРР-2181/06.02.2013; НСР-12833/26.05.2017; НСР-16586/24.08.2018 |
08.09.2018 |
02.01.2019 |
Активен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
15.9 |
3.18 |
19.08 |
6% |
0.95 |
16.85 |
3.37 |
20.22 |
18% |
2.86 |
19.71 |
3.94 |
23.65 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013; НСР-12833/26.05.2017; НСР-16586/24.08.2018 |
08.09.2018 |
02.10.2018 |
Неактивен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
16.04 |
3.21 |
19.25 |
6% |
0.96 |
17 |
3.4 |
20.4 |
18% |
2.89 |
19.89 |
3.98 |
23.87 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013; НСР-12833/26.05.2017 |
10.06.2017 |
02.07.2017 |
Неактивен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
18.07 |
3.61 |
21.68 |
6% |
1.08 |
19.15 |
3.83 |
22.98 |
18% |
3.25 |
22.4 |
4.48 |
26.88 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013 |
03.03.2013 |
02.08.2016 |
Неактивен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, prolonged‐release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия ; Pfizer Manufacturing Deutschland GmbH, Германия |
18.07 |
3.61 |
21.68 |
6% |
1.08 |
19.15 |
3.83 |
22.98 |
18% |
3.25 |
22.4 |
4.48 |
26.88 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013 |
03.03.2013 |
03.03.2013 |
Неактивен |
1651 |
| Venlafaxine |
II-9536/ 18.08.2004 |
EFECTIN ER 150, prolonged‐release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Wyeth Medica - Ireland - Ирландия |
45.67 |
9.13 |
54.8 |
4% |
1.83 |
47.5 |
9.5 |
57 |
16% |
7.31 |
54.81 |
10.96 |
65.77 |
промяна на обстоятелства решение КЦPP-1461/02.10.2012 |
КЦРР-385/29.03.2012 |
24.04.2012 |
24.04.2012 |
Неактивен |
1651 |
| Venlafaxine |
II-9536/18,08,2004 |
EFECTIN ER 150, prolonged‐release capsule, hard, 150, mg, Pack: 28 |
Wyeth Lederle Pharma GmbH, Австрия |
Wyeth Medica - Ireland - Ирландия |
72.09 |
14.42 |
86.51 |
4% |
2.88 |
74.97 |
14.99 |
89.96 |
16% |
11.53 |
86.5 |
17.3 |
103.8 |
|
КЦ-397/07.01.2009 |
30.01.2009 |
30.01.2009 |
Неактивен |
1651 |
| Venlafaxine |
9800390 |
EFECTIN ER 75, Prolonged release capsule, hard, 75, mg, Pack: 28 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Ireland Pharmaceuticals, Ирландия ; Pfizer Manufacturing Deutschland GmbH, Германия |
8.59 |
1.72 |
10.31 |
7% |
0.6 |
9.19 |
1.84 |
11.03 |
20% |
1.72 |
10.91 |
2.18 |
13.09 |
промяна на обстоятелства НСР-9774/14.07.2016; НСР-17431/06.12.2018 |
КЦРР-2181/06.02.2013; НСР-12834/26.05.2017; НСР-15687/17.05.2018 |
01.06.2018 |
02.01.2019 |
Активен |
1650 |
| Venlafaxine |
9800390 |
EFECTIN ER 75, Prolonged release capsule, hard, 75, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия ; Pfizer Manufacturing Deutschland GmbH, Германия |
8.59 |
1.72 |
10.31 |
7% |
0.6 |
9.19 |
1.84 |
11.03 |
20% |
1.72 |
10.91 |
2.18 |
13.09 |
промяна на обстоятелства НСР-9774/14.07.2016 |
КЦРР-2181/06.02.2013; НСР-12834/26.05.2017; НСР-15687/17.05.2018 |
01.06.2018 |
02.06.2018 |
Неактивен |
1650 |
| Venlafaxine |
9800390 |
EFECTIN ER 75, Prolonged release capsule, hard, 75, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия ; Pfizer Manufacturing Deutschland GmbH, Германия |
9.47 |
1.89 |
11.36 |
7% |
0.66 |
10.13 |
2.03 |
12.16 |
20% |
1.89 |
12.02 |
2.4 |
14.42 |
промяна на обстоятелства НСР-9774/14.07.2016 |
КЦРР-2181/06.02.2013; НСР-12834/26.05.2017 |
03.03.2013 |
02.07.2017 |
Неактивен |
1650 |
| Venlafaxine |
9800390 |
EFECTIN ER 75, Prolonged release capsule, hard, 75, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия ; Pfizer Manufacturing Deutschland GmbH, Германия |
10.95 |
2.19 |
13.14 |
6% |
0.66 |
11.61 |
2.32 |
13.93 |
18% |
1.97 |
13.58 |
2.72 |
16.3 |
промяна на обстоятелства НСР-9774/14.07.2016 |
КЦРР-2181/06.02.2013 |
03.03.2013 |
02.08.2016 |
Неактивен |
1650 |
| Venlafaxine |
9800390 |
EFECTIN ER 75, prolonged‐release capsule, hard, 75, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия ; Pfizer Manufacturing Deutschland GmbH, Германия |
10.95 |
2.19 |
13.14 |
6% |
0.66 |
11.61 |
2.32 |
13.93 |
18% |
1.97 |
13.58 |
2.72 |
16.3 |
промяна на обстоятелства НСР-9774/14.07.2016 |
КЦРР-2181/06.02.2013 |
03.03.2013 |
03.03.2013 |
Неактивен |
1650 |
| Venlafaxine |
II-9536/ 18.08.2004 |
EFECTIN ER 75, prolonged‐release capsule, hard, 75, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Wyeth Medica - Ireland - Ирландия |
22.51 |
4.5 |
27.01 |
6% |
1.35 |
23.86 |
4.77 |
28.63 |
18% |
4.05 |
27.91 |
5.58 |
33.49 |
промяна на обстоятелства решение КЦPP-1461/02.10.2012 |
КЦРР-385/29.03.2012 |
24.04.2012 |
24.04.2012 |
Неактивен |
1650 |
| Venlafaxine |
II-9535/18,08,2004 |
EFECTIN ER 75, prolonged‐release capsule, hard, 75, mg, Pack: 28 |
Wyeth Lederle Pharma GmbH, Австрия |
Wyeth Medica - Ireland - Ирландия |
36.14 |
7.23 |
43.37 |
4% |
1.45 |
37.59 |
7.52 |
45.11 |
16% |
5.78 |
43.37 |
8.67 |
52.04 |
|
КЦ-397/07.01.2009 |
30.01.2009 |
30.01.2009 |
Неактивен |
1650 |
| Venlafaxine |
5333/03.07.2009 |
Efexiva, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Sandoz d.d., Словения |
Salutas Pharma GmbH Lek S.A. Lek Pharmacaceuticals d.d. |
7.41 |
1.48 |
8.89 |
7% |
0.52 |
7.93 |
1.59 |
9.52 |
20% |
1.48 |
9.41 |
1.88 |
11.29 |
Цената е заличена с решение НСР-3620/29.05.2014 ( в сила от 13.06.2014) |
НСР-2129/14.12.2013 |
30.12.2013 |
30.12.2013 |
Заличен |
2360 |